作者: Pei-Pei Kung
DOI:
关键词:
摘要: Compounds of formula (I) are disclosed, as well methods for synthesizing such compounds and their use. Preferred potent inhibitors c-MET/HGFR useful in the treatment a variety HGFR-mediated disorders, including cancers.